Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Yamanouchi and Boehringer Ingelheim to copromote Flomax in U.S. for BPH

Aug. 18, 2004

Yentreve approved in E.U. for stress urinary incontinence

Aug. 18, 2004

Sanctura distribution under way

Aug. 17, 2004

Good efficacy and safety shown for long-term use of Sanctura

Aug. 4, 2004

European approval recommended for Emselex

Aug. 3, 2004

Further positive phase I/II data for NX-1207 in BPH

Aug. 2, 2004

Chinese researchers identify novel agents for renal disorders

July 30, 2004

Novel dopamine D3 agonists and their use in sexual disorders

July 29, 2004

INNOVATION study of Micardis completes enrollment

July 28, 2004

Abbott and Deltanoid to develop fourth generation active D therapies

July 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...